Treatment of Leishmaniasis With Impavido® (Miltefosine): Higher-Weight Patient Registry
Condition(s):LeishmaniasisLast Updated:August 28, 2020Withdrawn
Hide Studies Not Open or Pending
Condition(s):LeishmaniasisLast Updated:August 28, 2020Withdrawn
Condition(s):Mucocutaneous LeishmaniasisLast Updated:September 4, 2020Completed
Condition(s):Cutaneous LeishmaniasisLast Updated:September 12, 2019Completed
Condition(s):Leishmaniasis or Other Uses of MiltefosineLast Updated:March 7, 2018Recruiting
Condition(s):Cutaneous LeishmaniasisLast Updated:August 22, 2016Completed
Condition(s):Post Kala Azar Dermal LeishmaniasisLast Updated:August 21, 2019Completed
Condition(s):Mucocutaneous LeishmaniasisLast Updated:March 4, 2019Completed
Condition(s):Mucosal Leishmaniasis; Cutaneous LeishmaniasisLast Updated:September 30, 2020Completed
Condition(s):Cutaneous LeishmaniasisLast Updated:April 7, 2020Completed
Condition(s):Leishmaniasis, CutaneousLast Updated:February 27, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.